Our study provides a novel example of using genome editing in zebrafish to demonstrate how a human DNA sequence variant of unknown significance may contribute to the complex genetics of congenital heart defects.
Introduction
Whole-genome and whole-exome sequencing efforts are increasingly identifying genetic variation in the general human population as well as candidate genetic variants associated with disease (Lek et al., 2016; Wright et al., 2015) . There are several approaches for predicting and testing the pathogenicity of a genetic variant (Cox et al., 2015; Richards et al., 2015; Starita et al., 2017) . However, demonstrating a function of a particular sequence variant remains challenging. Genome editing now allows for the precise engineering of human genetic variants in animal models for rigorous functional testing (Doudna and Charpentier, 2014; Peng et al., 2014) . There are examples of the use of CRISPR-Cas9 engineering in mouse and C. elegans animal models to demonstrate functional effects of human disease-associated sequence variants (Arno et al., 2016; DiStasio et al., 2017; Lin et al., 2016; Prior et al., 2017) . However, it
is not yet clear how effectively human variants of unknown significance can be functionally tested through genome editing in animal models.
Congenital heart defects (CHDs) are a prominent example of a human disorder with complex genetics (reviewed in Fahed et al., 2013; Gelb and Chung, 2014; Zaidi and Brueckner, factors, or modifier genes, likely influence the phenotype of CHDs, but modifier genes are difficult to identify and characterize (Fahed et al., 2013; Gelb and Chung, 2014; Zaidi and Brueckner, 2017) . In order to understand the etiology of CHDs and the roles of genetic risk factors in influencing the phenotypic spectrum of CHDs, it is imperative that we increase our understanding of how genetic variants and modifier alleles regulate heart development and contribute to CHDs. Sequence variants in human PBX genes have been identified in patients with CHDs (Arrington et al., 2012; Slavotinek et al., 2017) , indicating that these PBX variants could contribute to CHDs. One of these variants, an inherited missense variant in the coding region of the PBX3 gene (p.A136V; 9:128678097 C>T), occurred at a frequency of 2.6% in a cohort of CHD patients (0.66% in controls; Arrington et al., 2012) . These patients exhibited a spectrum of CHDs, particularly outflow tract malformations (Arrington et al., 2012) . Pbx genes encode TALE (Three Amino acid Loop Extension)-class homeodomain-containing DNA-binding proteins, which have diverse roles in development and disease (Cerdá-Esteban and Spagnoli, 2014; Moens and Selleri, 2006) . In mouse embryos, Pbx1 is required for heart development, and loss of varying alleles of Pbx1, Pbx2, and Pbx3 leads to a spectrum of cardiac outflow tract defects (Chang et al., 2008; Stankunas et al., 2008) . Our previous studies have shown that zebrafish Pbx proteins are also needed for outflow tract development and are needed for early myocardial differentiation and morphogenesis (Kao et al., 2015; Maves et al., 2009) . The PBX3 p.A136V variant lies in a highly conserved poly-Alanine tract, which has been implicated in Pbx binding to histone deacetylase (HDAC) chromatin proteins (Saleh et al., 2000) . While this variant is predicted to be deleterious (Arrington et al., 2012) , it is not known whether it affects the function of PBX3 or contributes to CHD. Because this variant is present in controls and has the potential to be inherited, it may represent a modifier or risk factor for CHDs. The PBX3 p.A131V variant is present in the human population with an allele frequency of >0.6% (Arrington et al., 2012; ExAC, 2018) and so is likely excluded from studies of de novo or rare inherited variants associated with CHDs (Homsy et al., 2015; Jin et al., 2017; Sifrim et al., 2016; Zaidi et al., 2013) .
Here we use CRISPR-Cas9 genome editing in zebrafish to test whether the PBX3 p.A131V variant could function as a modifier allele in CHDs. In particular, we test whether this variant enhances the phenotype caused by loss of a cardiac specification factor, Hand2, in zebrafish heart development. Our study is the first example, of which we are aware, of using precision genome editing in zebrafish to demonstrate a function for a human disease-associated single nucleotide variant of unknown significance. Our work underscores the importance of testing the roles of inherited variants as genetic modifiers of CHDs.
Results
Zebrafish pbx4, but not pbx3b, is required for early cardiac morphogenesis An inherited heterozygous variant in PBX3, c.407C>T, predicting p.Arg136>Val, was previously identified as enriched in a cohort of patients with congenital heart defects (Arrington et al., 2012) . The allelic frequency of this variant was significantly less frequent in the study's control population (P=0.047; Arrington et al., 2012) and is also significantly less frequent in the current ExAC database population (P=0.0047, Chi-square test; ExAC, 2016). This PBX3 p.A136V variant is present in a highly conserved poly-Alanine tract, which lies between the two PBC domains that interact with HDAC and Meis proteins (Fig. 1A; Choe et al., 2009; Saleh et al., 2000) . The human and zebrafish Pbx genes that do not show 100% conservation of the poly-Alanine tract (human PBX4 and zebrafish pbx2 and pbx3a; Fig. 1A ) appear to have reduced functional roles in development, as human PBX4 variants are observed at near expected frequencies in the general population (ExAC, 2018) and zebrafish pbx2 null mutants are homozygous viable as adults (our unpublished data). However, loss of function variants in PBX3 are highly underrepresented in the ExAC database (ExAC, 2018) , suggesting that human PBX3 is required for viability. The enrichment of the PBX3 p.A136V variant in a CHD patient cohort suggests that it may contribute a modifier role in the complex genetics of congenital heart defects and led us to investigate a potential function of this allele in zebrafish.
In zebrafish and in mice, multiple Pbx genes are expressed broadly and have high functional redundancy (Capellini et al., 2004; Ferretti et al., 2011; Moens and Selleri, 2004; Pöpperl et al., 2000; Ruzicka et al., 2015) . Zebrafish have six pbx genes, and pbx3b is the closest ortholog of human PBX3 (Fig. 1B) . Neither pbx3b nor pbx3a are detectably expressed during early zebrafish development prior to about 48 hpf (hours post fertilization; Fig. 1C ; Ruzicka et al., 2015; Waskiewicz et al., 2002) . Because pbx3b has a conserved poly-Alanine tract ( Fig. 1A ) and shows upregulated expression by 48 hpf (Fig. 1C ) (after heart tube formation in zebrafish but around the stage of early outflow tract development; Grimes et al., 2006) , we tested the function of pbx3b by using CRISPR-Cas9 to generate zebrafish pbx3b mutants. The pbx3b scm8 mutation that we generated creates an early stop codon ( Fig. 1D ). We find that zebrafish pbx3b scm8/ scm8 larvae are viable and appear normal ( Fig. 1E ) and that pbx3b does not show any detectable requirements during early heart development, as heart tube formation, heart chamber formation, and outflow tract development appear grossly normal in pbx3b scm8/ scm8 embryos ( Fig. 1F-G) . pbx4, however, is the main zebrafish pbx gene expressed during early zebrafish development (Fig. 1C; Waskiewicz et al., 2002) . We have previously shown that zebrafish pbx4 is needed for proper heart and outflow tract development (Kao et al., 2015; Maves et al., 2009) . In particular, pbx4 mutant embryos show disrupted myocardial morphogenesis and variable defects in outflow tract development (Kao et al., 2015; Fig. 1F-G) .
Because Pbx genes have been shown to function redundantly (Capellini et al., 2006; Ferretti et al., 2011; Maves et al., 2007; Waskiewicz et al., 2002) , we tested whether pbx3b and pbx4 function redundantly during early myocardial morphogenesis and outflow tract development. We crossed our pbx3b scm8 strain with the pbx4 b557 null allele strain (Kao et al., 2015; Pöpperl et al., 2000) to generate pbx3b scm8/ scm8 ;pbx4 b557/b557 embryos. pbx4 b557/b557 and pbx3b scm8/scm8 ;pbx4 b557/b557 embryos both show variably disrupted formation of the myocardium and outflow tract ( Fig. 1F -G), but pbx3b scm8/scm8 ;pbx4 b557/b557 embryos do not appear to exhibit any more severe myocardial differentiation and outflow tract defects than those that we previously described for pbx4 b557/b557 embryos (Fig. 1F-G; Kao et al., 2015) . Thus, in zebrafish, pbx4, but not pbx3b, plays a critical function in early myocardial and outflow tract formation.
Studies of gene expression in early human embryos find that PBX3 is expressed at higher levels than other PBX genes (Yan et al., 2013) , similar to pbx4 in zebrafish (Fig. 1C ). Functional differences between Pbx genes have been argued to be more likely due to differences in expression than in biochemical activity (Moens and Selleri, 2006; Pöpperl et al., 2000) . Therefore, we decided to address the function of the human PBX3 p.A136V variant in the zebrafish pbx4 gene.
Engineering zebrafish pbx4 p.A131V variant strains
Compared to the human PBX3 p.A136 site, the zebrafish pbx4 gene has an orthologous site of A131 (nucleotide C392; Fig. 1A ; Fig. 2A ). To engineer zebrafish carrying the pbx4 p.A131V variant, we turned to the CRISPR-Cas9 system (Blackburn et al., 2013; Hwang et al., 2013; Hwang et al., 2015) . Although there have been recent improvements, most studies report a low efficiency of introducing precise base changes using CRISPR-Cas9 in zebrafish (Hoshijima et al., 2016; Shah and Moens, 2016; Zhang et al., 2017; Zhang et al., 2018; and references therein), Therefore, to optimize our efforts, we first wanted to ensure that we were using efficient CRISPR-component reagents.
We began by designing and testing synthetic guide RNAs. Two adjacent potential PAM sequences (NGG; 5' PAM and 3' PAM) are located 3' of the C392 nucleotide to be changed, so we designed guide RNAs that utilized these PAM sequences and overlapped the C392 nucleotide ( Fig. 2B -C). The first guide RNA (sgRNA-1) encompassed the 20 nucleotides (nt) 5' of the 5' PAM; the second (sgRNA-2) encompassed the 20 nt 5' of the 3' PAM; and the third (sgRNA-3) encompassed the 18 nt 5' of the 3' PAM ( Fig. 2C ). Synthetic single guide RNAs (sgRNA) were produced in vitro by annealing pairs of complementary oligos (Table 1) corresponding to the target sequences and ligating them into a plasmid vector containing a T7 promoter and the additional invariant sequences required to form the sgRNA (Hwang et al., 2013) . Subsequent transcription of the constructs by T7 polymerase results in the addition of a GG dinucleotide to the 5' end of the variable region of the sgRNA that binds to the target genomic sequence (Fig. 2C ). To test the ability of each sgRNA to induce insertions or deletions (indels) at the target locus, we injected one-cell stage zebrafish embryos with a mixture of Cas9 mRNA and one of the three sgRNAs, allowed the embryos to develop for 24 hrs, and then collected individual embryos for DNA analysis. Indels were detected by PCR-amplifying the region around the target site and digesting the amplicons with PstI, which has a recognition site within the target site ( Fig. 2B,D) . We observed a striking difference in the efficacy of the three sgRNAs. The first two sgRNAs produced no or extremely low levels of indels, with 0 out of 24 embryos for sgRNA-1 (not shown) and 0 out of 24 embryos for sgRNA-2 ( Next, we designed and tested synthetic single-stranded oligodeoxynucleotide donor templates (ssODNs) for introducing the pbx4 p.A131V variant through homology directed repair (HDR; Hwang et al., 2015) . We designed five ssODNs whose sequences overlap the C392 target site but contain a C392T change (corresponding to *C in Fig. 2B ; ssODNs listed in Table   1 ). One ssODN had 40 nt matching the genomic sequence on either side of the mis-matched T and corresponded to the sense strand (ssODN-1). Two oligos had 20 nt homology arms on either side of the base to be changed, with one oligo corresponding to the sense strand (ssODN-2) and the other to the anti-sense strand (ssODN-3). Finally, two oligos had 25 nt homology arms and corresponded to the sense (ssODN-4) and antisense (ssODN-5) strands.
We injected zebrafish embryos with Cas9 mRNA + sgRNA-3 + each ssODN, allowed the embryos to develop for 24 hours, and then assayed them for the presence of indels (using the PstI digest, as above for the sgRNA assays) and for the introduction of the C to T change. To detect the specific base change, we designed PCR primers that would create a new AccI restriction site when C392 was changed to a T. Of the five ssODNs tested, two produced detectable levels of the restriction fragment expected from introduction of the C to T base change in some injected embryos (ssODN-4: 5/12 embryos; ssODN-5: 2/12 embryos). The remaining three oligos induced no detectable levels of C to T base change. None of the ssODNs appeared to affect the frequency of induction of indels, with all injection conditions yielding approximately 90% of embryos with some level of indels (similar to that shown in Fig.   2D ; data not shown).
Based on these results, we then co-injected the pbx4 guide RNA (sgRNA-3), Cas9 mRNA, and the ssODN-4 oligo into 1-cell zebrafish embryos and raised these F0 animals to adulthood. We screened adult F0 fish for those transmitting germline pbx4 p.A131V mutations by assaying their F1 embryos for incorporation of the C392T mutation, using the same PCR and restriction fragment length polymorphism analysis used in screening the ssODNs ( Fig. 2E ). Out of 60 F0 adults screened, we identified two independent founder fish transmitting the precise C392T change. We also identified founders carrying a variety of additional alleles (indels) around the pbx4(C392) site (data not shown). We bred F0 fish to wild-type fish to generate F1 fish. We then identified F1 adult fish heterozygous for the precise desired pbx4 p.A131V variant ( Fig. 2F-G) . These F1 fish were then bred to wild-type fish to generate a zebrafish strain, pbx4 scm14 , carrying the pbx4 p.A131V variant (Fig. 2G ). We sequenced the pbx4 gene in the pbx4 scm14 strain to confirm that there were no other changes introduced in pbx4 (data not shown).
Upon genotyping adult fish derived from a pbx4 scm14/+ X pbx4 scm14/+ cross, we find the expected frequency of pbx4 scm14/scm14 fish (7/32 fish; Chi-square test, P=0.7788), showing that we obtain viable homozygous adults for the pbx4 p.A131V variant, while homozygous null pbx4 b557/b557 animals die at about 5 days post fertilization (Pöpperl et al., 2000) . The adult viability suggests that the pbx4 p.A131V variant does not, on its own, lead to a significant defect in heart development (as we further confirm below).
To test of the strength of the pbx4 p.A131V allele, we crossed the pbx4 scm14 strain with the null pbx4 b557 strain. From a cross of pbx4 scm14/+ fish with pbx4 b557/+ fish, we find that transheterozygous pbx4 scm14/b557 fish survive to adulthood and are present at the expected frequency (10/43 fish; Chi-square test, P=0.2640). This suggests that the pbx4 p.A131V allele is likely a weakly hypomorphic allele. We then used the new pbx4 variant allele strain to test whether the pbx4 p.A131V variant functions as a genetic modifier of other CHD genes.
The pbx4 p.A131V variant enhances loss of the CHD gene hand2
To further test the function of the pbx4 p.A131V allele, we next wanted to additionally perturb the genetic burden of fish carrying the pbx4 p.A131V allele. In particular, we decided to directly test whether the pbx4 p.A131V variant functions as a genetic modifier and enhances the phenotype caused by loss of a known CHD gene, hand2. hand2 encodes a basic helix-loophelix factor that has critical requirements for embryonic heart development in zebrafish and mice (Srivastava et al., 1997; Yelon et al., 2000) , and mutations in the human HAND2 gene have been associated with CHD (Lu et al., 2016; Shen et al., 2010; Sun et al., 2016; Töpf et al., 2014) . In zebrafish, hand2 is required for both cardiomyocyte differentiation and early myocardial morphogenesis (Garavito et al., 2010; Schoenebeck et al., 2007; Trinh et al., 2005; Yelon et al., 2000; ) . Furthermore, our previous work used morpholino knockdowns to show that hand2 and pbx4 act together in zebrafish early myocardial morphogenesis (Maves et al., 2009) .
We therefore crossed our pbx4 p.A131V allele strain (pbx4 scm14 ) with the established null mutant strain, hand2 s6 (Yelon et al., 2000) . We additionally included the pbx4 b557 null allele in these crosses. Fig. 3A shows the genetic crosses used to obtain embryos of all possible homozygous and heterozygous mutant combinations needed for our analyses.
We examined early cardiac phenotypes in embryos from these crosses at 24 hpf, using RNA in situ expression of myl7 to examine myocardial precursors. At 24 hpf, wild-type embryos have formed a heart tube ( Fig. 3B ; Staudt et al., 2012) , and pbx4 scm14/scm14 embryos also appear to have a normal heart tube (not shown). As previously described, pbx4 b557/b557 embryos show an abnormally-shaped, medially-positioned myocardium ( Fig. 3C ; Kao et al., 2015) , and hand2 s6/s6 embryos show reduced, medial, crescent-shaped myocardial domains that have not assembled together properly, with defective fusion of the myocardial precursors at the midline ( Fig. 3D; Yelon et al., 2000) . We quantified the myocardial fusion defects in these embryos by measuring the distance between the myl7 domains (Fig. 3H) . The hand2 s6/s6 myocardial fusion defect is significantly more severe in pbx4 b557/b557 ;hand2 s6/s6 embryos, in that the myl7 domains have greater bilateral separation (Fig. 3F,H) . We find that pbx4 scm14/b557 ;hand2 s6/s6 embryos also show a more severe effect on myocardial fusion than that seen in hand2 s6/s6 embryos, and, critically, the defect is also more severe than that seen in pbx4 b557/+ ;hand2 s6/s6 embryos, or in pbx4 scm14/scm14 ;hand2 s6/s6 embryos. (Fig. 3E-H) . These results show that the pbx4 p.A131V variant, combined with a null pbx4 allele, increases the severity, or enhances, the myocardial morphogenesis phenotype caused by loss of hand2 function. We also analyzed the frequencies of myocardial phenotypes in embryos from these crosses ( Table 2) . We classified embryos as having a wild-type heart tube, a medial heart cone (the pbx4 b557/b557 phenotype), a medial crescent (the hand2 s6/s6 phenotype), or a bilateral domain phenotype (the pbx4 b557/b557 ;hand2 s6/s6 phenotype). This analysis also shows that the myocardial fusion defect is more severe in pbx4 scm14/b557 ;hand2 s6/s6 embryos than in hand2 s6/s6 embryos, pbx4 b557/+ ;hand2 s6/s6 embryos, or pbx4 scm14/scm14 ;hand2 s6/s6 embryos (Table 2) . Together, these results demonstrate that the pbx4 p.A131V variant functions as a genetic modifier and enhances the myocardial morphogenesis phenotype caused by loss of hand2 function. Therefore, even though the pbx4 p.A131V fish are viable and do not have obvious heart defects in an otherwise wild-type genetic background, our results support our hypothesis that the pbx4 p.A131V allele can function as a genetic modifier in heart development.
Discussion
Here we used CRISPR-Cas9 precision genome editing to successfully engineer a zebrafish strain with a PBX3 p.A131V variant of unknown significance that was previously identified in a cohort of patients with CHDs. We engineered the human variant into the homologous pbx4 p.A131V site in zebrafish. We used the engineered zebrafish to demonstrate that the pbx4 p.A131V allele acts as a genetic enhancer of the known CHD gene hand2. Our work underscores the importance of testing the roles of inherited variants as genetic modifiers of CHDs. Our study is the first example, of which we are aware, of using precision genome editing in zebrafish to demonstrate a function for a human disease-associated variant of unknown significance. Our work provides a novel approach toward advancing our understanding of the complex genetics of CHDs and also provides an example for using genome editing in zebrafish to test the causal roles and genetic interactions of human disease-associated DNA variants.
Many approaches in zebrafish and mammalian models have been previously used to characterize functions of human heart disease-associated DNA sequence variants. One study showed that zebrafish embryos could be used to characterize heart function defects caused by a human sodium channel gene SCN5A variant, which is strongly associated with human heart disorders such as arrhythmias (Huttner et al., 2013) . However, this study employed overexpression of the human gene in transgenic zebrafish. Zebrafish embryos have often been used to test the functions of potential human disease variants through complementation, in which the orthologous zebrafish gene is typically knocked out through genetic mutation or knocked down with antisense morpholinos, and then mRNA injections of a human wild-type or mutant form are used to attempt rescue of a phenotype (Davis et al., 2014) . However, due to the inherent transient and mosaic nature of the mRNA injection and overexpression approach, these complementation assays have challenges for examining genetic interactions. A CHDassociated GATA4 variant has been functionally characterized in a mouse model (Misra et al., 2012) , but this was done with conventional embryonic stem cell targeting, which incorporates a targeting vector into the genome. This same GATA4 variant was also functionally characterized in patient-derived cardiomyocytes induced from pluripotent stem cells, and this analysis provided a deep, systems-level mechanistic understanding of how this particular variant disrupts cardiomyocyte gene expression and function (Ang et al., 2016) . However, such cell culture models also have challenges for examining genetic interactions and may not reveal the full effects of a variant on a gene's function in vivo.
While the development of CRISPR-Cas9 technology has made possible the creation of targeted single-nucleotide changes in zebrafish, the process is still inefficient. Our studies support optimization of the component reagents for successful single-nucleotide editing. We found that different sgRNAs and ssODNs had very different efficacies. Of the three sgRNAs tested, two failed to induce indels at a level we could detect with an RFLP assay, while the third resulted in readily detectable indels in nearly all injected embryos. The highly effective sgRNA has a 20 nt targeting region with a single mis-match at the second position, whereas the ineffective sgRNAs had 22 nt targeting regions and 2 mismatches at their 5' ends. While sgRNAs with 22 nt protospacers have been used in zebrafish effectively (Hwang et al., 2013) , most published studies have used sgRNAs with 20 nt protospacers. One-or two-base mismatches at or near the 5' end of the protospacer have been shown to be tolerated (Cong et al., 2013; Gagnon et al., 2014; Hwang et al., 2013) , and a guanine immediately 5' to the PAM sequence has been shown to correlate positively with indel frequencies (Farboud and Meyer 2014; Gagnon et al., 2014) . Thus, the high incidence of indels seen with pbx4 sgRNA-3 may result from a combination of optimal protospacer length, the presence of only a single mismatch near the 5' end of the protospacer, and a G nucleotide in the final position of the protospacer before the PAM. Less is known about the design of homology-directed repair templates to maximize precise editing, and there is conflicting evidence as to whether ssODNs are more efficient at introducing single nucleotide changes than long double-stranded DNA repair templates (Boel et al., 2016; Hoshijima et al., 2016; Hruscha et al., 2013; Hwang et al., 2013; Irion et al., 2014; Liang et al., 2017; Zhang et al., 2018) . Previous studies have achieved template-mediated repair using ssODNs of similar length, or longer, to our ssODN-4 (Boel et al., 2016; Hruscha et al., 2013; Hwang et al., 2013; Liang et al., 2017) , but homology arms shorter than about 25 nt appear to be ineffective, as we found with our ssODN-2 and ssODN-3.
Our study provides further support for critical roles for PBX-related TALE-class homeodomain transcription factors in heart development and CHDs. Pbx1, Pbx2, and Pbx3 proteins and the Pbx-related factor Meis1 all contribute to outflow tract development in mouse embryos (Chang et al., 2008; Stankunas et al., 2008) . Zebrafish pbx and meis genes are also needed for proper heart development (Guerra et al., 2018; Kao et al., 2015; Maves et al., 2009; Paige et al., 2012) . In human cardiomyocyte cell culture models, DNA binding sites for PBX and MEIS factors have been identified as enriched in open chromatin and occurring nearby sites for other cardiac transcription factors (He et al., 2011; Paige et al., 2012; Stergachis et al., 2013; Wamstad et al., 2012) . Human sequencing studies have found PBX and MEIS gene variants associated with CHDs (Arrington et al., 2012; Crowley et al., 2010; Louw et al., 2015; Slavotinek et al., 2017) . Notably, a recent study described five patients, each with a CHD and other congenital anomalies, that all had de novo missense or nonsense sequence variants in PBX1 (Slavotinek et al., 2017) . The missense PBX1 variants occurred in or near the homeodomain and likely affect the transcriptional capabilities of PBX1 (Slavotinek et al., 2017) . The PBX3 p.A136V variant that we addressed here is in the more N-terminal poly-Alanine tract, which may bind HDAC proteins (Saleh et al., 2000 , although see Choe et al., 2009 ). The poly-Alanine tract is adjacent to the PBC domains, which interact with Meis and HDAC proteins (Choe et al., 2009; Mann et al., 2009; Saleh et al, 2009 ). Even though one caveat of our study is that we model the human PBX3 variant in the zebrafish pbx4 locus, the poly-Alanine tract is highly conserved in both PBX3 and Pbx4. As future studies identify additional inherited and de novo variants in PBX genes associated with CHDs, we will gain a better understanding of which human PBX genes, and which PBX protein domains, are needed for human heart development.
Our study also provides further support for the oligogenic basis of CHDs. Previous studies of Pbx genes in mouse heart development supported a multigenic basis for CHDs (Stankunas et al., 2008) . A study that found family members carrying the same HAND2 mutation, but exhibiting different cardiac defects (Sun et al., 2016) , also supports a role for multiple genetic changes influencing the severity of CHDs. In order to reveal a contribution of the pbx4 p.A131V variant in zebrafish heart development, we had to employ an additional null allele of pbx4 as well as homozygous loss of hand2, conditions that are likely not present in human CHD cases. However, we do not yet have an understanding of the full genetic burden of variants in human CHD cases. A recent study found evidence for rare inherited variants, in genes with a known association with cardiac malformations, in parent-child trios affected by atrioventricular septal defects, and these particular rare variants were generally not observed in control trios (Priest et al., 2016) . This study, and our work, support the idea that inherited variants across multiple genetic loci may contribute to the penetrance and expressivity of congenital heart defects, and provide further support to the oligogenic inheritance of CHDs (Fahed et al., 2013; Gelb and Chung, 2014) . Forward genetics in mice was used recently to identify an interaction between two genes, Sap130 and Pcdha9, in causing hypoplastic left heart syndrome (HLHS; Liu et al., 2017) . Intriguingly, this study also identified one human HLHS subject with variants in both SAP130 and PCDHA13, a Pcdha9 homolog (Liu et al., 2017) . In mice, Sap130 and Pcdha9 may work combinatorially, each regulating different pathways important for proper heart development (Liu et al., 2017) . Although we previously described pbx4 and hand2 as working together in zebrafish heart development (Maves et al., 2009) , it is possible that they are also working through parallel pathways. Future studies that continue to take advantage of animal models, as well as human genetic sequence data, will further enhance our understanding of the complex genetics of human diseases such as CHD.
Materials and Methods

Zebrafish husbandry
All experiments involving live zebrafish (Danio rerio) were carried out in compliance with Seattle Children's Research Institute IACUC guidelines. Zebrafish were raised and staged as previously described (Westerfield, 2000) . Staging time refers to hours post fertilization (hpf) at 28.5 °C. The wild-type stock and genetic background used was AB. The pbx4 b557 mutant strain was previously described and is likely a null allele (Pöpperl et al., 2000) . pbx4 b557 genotyping was performed as previously described (Kao et al., 2015) using forward primer 5′ACTCGGCGGACTCTCGCAAGC3′ and reverse primer 5′GGCTCTCGTCGGTGATGGCCATGATCT3′. The genotyping PCR product is 128 base pairs; digesting with XbaI yields a 98 base pair product from the mutant allele. In some cases, pbx4 b557 animals were genotyped using a KASP assay (LGC Genomics). Reactions were run and fluorescence was measured in a Bio-Rad CFX96, and genotypes were assigned using the Bio-Rad CFX Manager software, according to instructions provided by LGC. Details for ordering the pbx4 b557 KASP assay are available upon request. The hand2 s6 mutant strain was previously described and is a deletion of the hand2 locus (Yelon et al., 2000) . For hand2 s6 genotyping, we devised a qPCR assay for the number of copies of the hand2 gene. hand2 was amplified with forward primer 5'ACCAAAGCGTACTCCGTCTG3' and reverse primer 5'CAGCGAAGGAATAGCCGTCA3'. pbx4 was also amplified as a normalization control using forward primer 5'GCCGTTAAAACAGCCGTGG3' and reverse primer 5'GTGTTGCTGGAGAGTTTGCC3'. Reactions were run in duplicate for both genes using the KAPA SYBR FAST kit (KAPA Biosystems KK4600) on a Bio-Rad CFX96 machine, the resulting Ct values were averaged, and a Ct was calculated to distinguish hand2 homozygous, heterozygous, and wild-type embryos.
Pbx phylogenetic analysis
Accession numbers for the sequences aligned in Figure 1A are given in Table 3 .
Sequences were aligned using Clustal Omega (www.EMBL.org). The phylogeny was constructed with PhyML using the following settings: Substitution Model LG; Tree Improvement SPR & NNI; Bootstrapping 500 (www.ATGC-montpellier.fr). The phylogenetic tree ( Figure 1B) was drawn with TreeDyn (www.phylogeny.lirmm.fr).
qRT-PCR
Total RNA was isolated using TriZol (Ambion; Thermo Fisher Scientific) and reversetranscribed with the SensiFAST cDNA Synthesis kit (Bioline BIO-65053). Primers were designed using Primer-BLAST such that they either span an intron or one of the pair spans an exon-exon boundary. Primers are listed in Table 4 . Real-time PCR was carried out using the KAPA SYBR FAST kit (KAPA Biosystems KK4600) on a Bio-Rad CFX96 machine. Ct values for the zebrafish pbx genes were corrected for observed primer efficiencies and normalized to odc1.
Generation of mutant zebrafish strains with CRISPR-Cas9
Single guide constructs were made by annealing pairs of oligos (listed in Table 1 ) and ligating them into BsaI-digested pDR274 (Hwang et al., 2013) . The single guide plasmids were digested with DraI, and guide RNA was transcribed with the T7 Maxiscript kit (Ambion; Thermo Fisher Scientific). Cas9 mRNA was made by transcribing PmeI-digested pMLM3613 (Hwang et al., 2013) with the T7 Ultra kit (Ambion; Thermo Fisher Scientific). One-cell-stage zebrafish embryos were injected with 600pg (for pbx3b) or 400pg (for pbx4) of Cas9 mRNA and 25pg of a single guide RNA in a volume of 2nL. To generate the desired single nucleotide change in pbx4, 50pg of an ssODN (Table 1) was co-injected with Cas9 mRNA and the single guide RNA.
Zebrafish were screened for Cas9-generated mutations (insertions or deletions, "indels") by amplifying with primers flanking the target site (indel assay primers, Table 1 ) followed by a digest to test for loss of a restriction site just upstream of or overlapping the PAM site (HpyAV for pbx3b, PstI for pbx4). To detect the single-nucleotide change in pbx4, a dCAPS assay was designed (http://helix.wustl.edu/dcaps/; Neff et al., 1998) such that PCR amplification of the mutant allele generated an AccI site (pbx4 dCAPS assay primers in Table 1 ). Mutant alleles were identified in heterozygous F1 or F2 fish by Sanger sequencing and deconvolving the chromatograms with Poly Peak Parser (http://yosttools.genetics.utah.edu/PolyPeakParser/).
Whole-mount RNA in situ hybridization and measurement analysis
The following cDNA probes were used: myl7 (Yelon et al., 1999) and elnb (Miao et al., 2007) . Whole-mount in situ hybridization colorimetric and fluorescent in situ staining was performed as previously described (Maves et al., 2007; Talbot et al., 2010) , with the following modifications. Embryos at 60 hpf were depigmented in 1 part 0.1% KOH (vol.): 1 part 1X PBS-0.1% Tween (vol.): 0.1 part 30% hydrogen peroxide (vol.) for 2 hours at room temperature with gentle agitation. Hybridizations for both colorimetric and fluorescent in situ experiments were performed in hybridization buffer with 5% dextran sulfate. Following staining, tail clips from postin situ hybridized embryos were lysed and genotyped for pbx3b scm8 , pbx4 b557 , pbx4 scm14 , and hand2 s6 as above. Fluorescent in situs were imaged on a Leica SP5 confocal with a 40x water immersion objective.
For myl7 measurements, 24 hpf embryos stained for myl7 were individually imaged at a consistent magnification on a stereomicroscope. ImageJ was used to measure the area of myl7 expression and the distance between bilateral domains of expression, expressed in pixels. For embryos with separate bilateral myl7 domains, three distance measurements were made for each embryo: between the medial edges of expression at the anterior extent of expression, between the medial edges of expression at the posterior extent of expression, and at the approximate midpoint between the anterior and posterior measurements. These three values were then averaged. For embryos with a single midline domain of myl7 expression, a distance value of 0 was assigned. For embryos with a crescent-shaped domain, the posterior distance measurement was 0 and the middle and anterior measurements were made as for separate bilateral domains. The averages for the myl7 distances among the different genotypes were compared using one-way ANOVA and p-values were corrected for multiple comparisons using Tukey's test. ANOVA was performed and the box plots were made in GraphPad Prism 7. The boxes extend from the 25th to 75th percentiles, the whiskers are at the minimum and maximum, and the bar within the box represents the median. Numbers indicate total number of embryos of each genotype with the indicated myocardial phenotype class. Shaded cells indicate genotypes/phenotypes that were compared by Fisher's exact test: pbx4 scm14/b557 ;hand2 s6/s6 versus pbx4 +/+ ;hand2 s6/s6 , P=0.0013; pbx4 scm14/b557 ;hand2 s6/s6 versus pbx4 b557/+ ;hand2 s6/s6 , P=0.021; pbx4 scm14/b557 ;hand2 s6/s6 versus pbx4 scm14/scm14 ;hand2 s6/s6 , P=0.0011. 
